MIRA INFORM REPORT

 

 

Report Date :

26.02.2011

 

IDENTIFICATION DETAILS

 

Name :

GEMINI INDÚSTRIA DE INSUMOS FARMACÊUTICOS LTDA

 

 

Registered Office :

Via Primária 4d, S/Nº, Quadra 08a, Módulos I E Ii - Daia , Zip Code 75133-590 - Anápolis/Go

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

23.01.2009

 

 

Legal Form :

Limited Liability Company      

 

 

Line of Business :

Manufacture, Import and Distribution of Pharmaceutical Products

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 100.000,00

 

 

Status :

New Company

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

Brazil

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name

 

GEMINI INDÚSTRIA DE INSUMOS FARMACÊUTICOS LTDA

 

 

Company ADDRESSES

 

MAIN ADDRESS:

VIA PRIMÁRIA 4D, S/Nº, QUADRA 08A, MÓDULOS I E II - DAIA

ZIP CODE/CITY:

75133-590 - ANÁPOLIS/GO

 

 

PHONE:

11 2067-5610

FAX:

11 2215-8823

E-MAIL:

api@purifarma.com.br

 

BRANCHES:

 

NOT AVAILABLE.

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

23/01/2009

REGISTER DATE:

12/03/2009

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER (CNPJ):

10.690.195/0001-00

STATE REGISTER:

10.450.596-6

 

 

SHARE CAPITAL:

R$ 3.000.000,00

PAID UP CAPITAL:

R$ 2.381.000,00

 

 

BOARD OF DIRECTORS:

 

 

 

IVAN DA GLÓRIA TEIXEIRA

DIRECTOR

 

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTOR IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 


 

SHAREHOLDERS / PARTNERS:

 

 

 

JÚLIO TOMIZO TANAKA

50%

VALDETE VIODRES TANAKA

50%

 

AFFILIATES / SUBSIDIARIES:

 

LEVIALE INDÚSTRIA COSMÉTICA LTDA

GENIX - INDÚSTRIA FARMACÊUTICA LTDA

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JANUARY 23, 2009 TO BE ENGAGED IN THE SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

THE COMPANY OPERATES WITH THE TRADE NAME "GEMINI INDÚSTRIA E COMÉRCIO LTDA".

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2010 AND 31/12/2009.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2010

31/12/2009

 

 

 

 

 

CASH

95,71

673,67

 

BANKS

70.721,09

5.586,65

 

ADVANCES

33.229,51

7.474,17

 

CLIENTS

541.528,98

 

 

RECOVERABLE TAXES

15.234,02

 

 

INVENTORY

1.239.166,25

 

 

 

----------------

----------------

 

TOTAL CURRENT ASSETS

1.899.975,56

13.734,49

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

910.579,94

840.005,25

 

DEFERRED

200.384,80

33.348,80

 

 

----------------

----------------

 

TOTAL FIXED ASSETS

1.110.964,74

873.354,05

 

 

================

================

 

TOTAL ASSETS

3.010.940,30

887.088,54

 

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2010

31/12/2009

 

 

 

 

 

SALARIES PAYABLE

7.307,92

4.088,87

 

SOCIAL OBLIGATIONS

5.214,50

3.667,33

 

PROVISIONS

9.985,93

1.773,17

 

TAXES & CONTRIBUTIONS

117.748,27

1.813,87

 

ACCOUNTS PAYABLE

1.385,85

34.745,30

 

SUPPLIERS

644.223,16

 

 

 

----------------

----------------

 

TOTAL CURRENT LIABILITIES

785.865,63

46.088,54

 

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

124.487,07

 

 

 

----------------

----------------

 

TOTAL LONG TERM LIABILITIES

124.487,07

 

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

2.381.000,00

841.000,00

 

PROFIT (LOSS) OF PERIOD

-280.412,40

 

 

 

----------------

----------------

 

TOTAL NET EQUITY

2.100.587,60

841.000,00

 

 

================

================

 

TOTAL LIABILITIES

3.010.940,30

887.088,54

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2010 AND 31/12/2009.

( FIGURES ARE IN REAIS ).

 

 

31/12/2010

31/12/2009

 

 

 

 

 

GROSS SALES

1.742.609,70

 

 

(-) TAXES ON SALES

243.364,18

 

 

 

----------------

----------------

 

NET SALES

1.499.245,52

 

 

(-) COST OF SOLD GOODS

1.575.577,80

 

 

 

----------------

----------------

 

GROSS PROFIT

-76.332,28

 

 

OPERATING REVENUE (EXPENSE)

-220.213,95

 

 

FINANCIAL REVENUE(EXPENSE)

16.133,83

 

 

 

----------------

----------------

 

OPERATIONAL PROFIT (LOSS)

-280.412,40

 

 

 

----------------

----------------

 

NET PROFIT (LOSS)

-280.412,40

 

 

 


 

MONTHLY SALES

 

  2010

 

 

 

---------------------

 

 

JANUARY

 

 

 

FEBRUARY

 

 

 

MARCH

 

 

 

APRIL

 

 

 

MAY

 

 

 

JUNE

 

 

 

JULY

 

 

 

AUGUST

 

 

 

SEPTEMBER

R$ 55.445,00

 

 

OCTOBER

R$ 824.193,60

 

 

NOVEMBER

R$ 350.914,40

 

 

DECEMBER

R$ 512.056,70

 

 

TOTAL

R$ 1.742.609,70

 

 

 

RATIOS:

31/12/2010

31/12/2009

 

 

QUICK RATIO

,84

 

,30

 

 

 

CURRENT RATIO

2,42

 

,30

 

 

 

ACCOUNTS RECEIVABLE TURNOVER

2,77

TIMES

 

 

 

 

DAYS' SALES IN RECEIVABLES

130,03

DAYS

 

 

 

 

INVENTORY TURNOVER

1,27

TIMES

 

 

 

 

ACCOUNTS PAYABLE PERIOD

147,20

DAYS

 

 

 

 

RETURN ON ASSETS

,50

TIMES

 

 

 

 

SALES TURNOVER ON NET EQUITY

,71

TIMES

 

 

 

 

NET WORTH TIE-UP

,43

 

1,00

 

 

 

INDEBTEDNESS

,43

 

,05

 

 

 

EQUITY RATIO

69,77

%

94,80

%

 

 

WORKING CAPITAL RATIO

141,77

%

-70,20

%

 

 

GENERAL SOLVENCY

3,31

 

19,25

 

 

 

RETURN ON NET EQUITY

-13,35

%

 

 

 

 

RETURN ON SALES (PROFIT MARGIN)

-18,70

%

 

 

 

 

GROSS PROFIT MARGIN

-5,09

%

 

 

 

 

OPERATIONAL RESULT

-18,70

%

 

 

 

 

SALES TURNOVER ON LIABILITIES

1,91

TIMES

 

 

 

 

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 1,67

 - OFFICIAL RATE ON 23/02/2011

US$ 1,00 = R$ 1,66

 - OFFICIAL RATE ON 31/12/2010

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/12/2009

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS LOW AND IT IS NOTED GOOD CURRENT RATIO AND POSITIVE WORKING CAPITAL AMOUNT. IN ADDITION IT ALREADY SHOWS AN INTERESTING SALES VOLUME BUT  NEGATIVE RESULT WAS MADE.

 

REMARK: THE 2009 PROFIT AND LOSS ACCOUNT IS NOT AVAILABLE DUE TO THE FACT THAT THE COMPANY STARTED ITS OPERATIONS IN 2010 ONLY.

 

REAL ESTATE:

NOT AVAILABLE.

 

VEHICLES:

NOT AVAILABLE.

 

MACHINES:

NOT AVAILABLE.

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

BANCO DO BRASIL S/A

3388-X / 62 3311-1633

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS.

 

IMPORT AND EXPORT:

 

 


IMPORTS FROM:

NOT AVAILABLE.

 

EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

NOT AVAILABLE.

 

STAFF:

 

THE COMPANY HAS: 3 EMPLOYEES

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A NEWLY-ESTABLISHED COMPANY, OPERATING SINCE 2009. SO FAR IT HAS A CLEAR TRADE HISTORY AND MODEST PAYMENT BEHAVIOUR.

 

THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES.

 

MAIN SUPPLIERS:

 

NOT AVAILABLE.

 

PAYMENT HISTORY:

 

1 SUPPLIER REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 1.044,00

 

AMOUNT OF INVOICES PAID: 3

TOTAL OF PROMPT PAYMENTS: 100%

 

 

FINAL OPINION

 

BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR NORMAL BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON MODERATE AMOUNTS ONLY DUE TO THE FACT THAT THE COMPANY STARTED ITS OPERATIONS VERY RECENTLY.

 

A CREDIT LIMIT OF USD 100.000,00 MAY BE GRANTED.

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.37

UK Pound

1

Rs.73.25

Euro

1

Rs.62.68

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.